Drugs / etinilestradiol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT06145438 | Sep 2023 → Aug 2024 | ovarian endometriosis | Universitas Diponegoro | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02393482 Comparator | Jun → Dec 2021 | amenorrhea, endometriosis | University of Cagliari | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | etinilestradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06145438 ↗ |
| Route | Oral | “one tablet orally daily” NCT02393482 ↗ |